Met Life Investment Management, LLC Adverum Biotechnologies, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.36 - $10.56 $80,277 - $252,299	-23,892 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$9.26 - $14.36 $221,239 - $343,089	23,892 New	23,892 $235,000
Q1 2021 Jun 26, 2023	BUY	$9.26 - $14.36 $221,239 - $343,089	23,892 New	23,892 $236 Million
Q1 2021 Mar 22, 2023	SELL	$9.26 - $14.36 $127,084 - $197,076	-13,724 Reduced 36.48%	23,892 $235,000
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $127,084 - $197,076	-13,724 Reduced 36.48%	23,892 $236,000
Q4 2020 Jun 22, 2023	BUY	$9.84 - $14.26 $370,141 - $536,404	37,616 New	37,616 $407,000
Q3 2020 May 24, 2024	BUY	$10.3 - $21.64 $51,613 - $108,438	5,011 Added 15.37%	37,616 $387 Million
Q3 2020 Jun 26, 2023	BUY	$10.3 - $21.64 $387,444 - $814,010	37,616 New	37,616 $387,000
Q3 2020 Mar 22, 2023	BUY	$10.3 - $21.64 $51,613 - $108,438	5,011 Added 15.37%	37,616 $387,000
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $51,613 - $108,438	5,011 Added 15.37%	37,616 $387,000
Q2 2020 May 24, 2024	BUY	$8.53 - $25.64 $278,120 - $835,992	32,605 New	32,605 $681 Million
Q2 2020 Jun 26, 2023	BUY	$8.53 - $25.64 $278,120 - $835,992	32,605 New	32,605 $680,000
Q2 2020 Mar 22, 2023	BUY	$8.53 - $25.64 $34,529 - $103,790	4,048 Added 14.18%	32,605 $680,000
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $34,529 - $103,790	4,048 Added 14.18%	32,605 $681,000
Q1 2020 Jul 12, 2023	BUY	$7.98 - $16.32 $227,884 - $466,050	28,557 New	28,557 $279,000
Q4 2019 Jul 12, 2023	BUY	$5.12 - $12.22 $146,211 - $348,966	28,557 New	28,557 $328,000
Q3 2019 Jul 12, 2023	BUY	$5.24 - $15.89 $149,638 - $453,770	28,557 New	28,557 $155,000
Q2 2019 Jul 12, 2023	BUY	$5.1 - $11.89 $145,640 - $339,542	28,557 New	28,557 $339,000
Q1 2019 Jul 13, 2023	BUY	$3.03 - $6.02 $86,527 - $171,913	28,557 New	28,557 $149,000
Q1 2019 Mar 22, 2023	SELL	$3.03 - $6.02 $46,710 - $92,804	-15,416 Reduced 35.06%	28,557 $149,000
Q1 2019 May 15, 2019	BUY	$3.03 - $6.02 $86,527 - $171,913	28,557 New	28,557 $150,000
Q4 2018 Feb 14, 2019	SELL	$2.87 - $5.92 $126,202 - $260,320	-43,973 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$4.5 - $7.6 $127,534 - $215,391	28,341 New	28,341 $171,000
Q3 2018 Mar 22, 2023	BUY	$4.5 - $7.6 $197,878 - $334,194	43,973 New	43,973 $266,000
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $70,344 - $118,803	15,632 Added 55.16%	43,973 $266,000
Q2 2018 Aug 15, 2018	BUY	$5.3 - $6.9 $150,207 - $195,552	28,341 New	28,341 $150,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.16 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$67,039
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$4,910
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $424M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account